Interestingly, the enrichment of the EMT pathway is not significant in patients with high levels of R3HDM1 in THCA and TGCT, which is consistent with the analysis of staging status in these two types of cancer, where the expression levels of R3HDM1 in stages I and II are significantly higher than in stages III and IV (Supplementary Figure 5). Here, R3HDM1 is linked to cancer.